AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
18:29
Dominic Fritz: USR Will Not Support the Investiture of a Government Without a Clear Majority
18:25
The European Commission disputes Moscow’s data on the money paid by the EU for Russian energy
18:19
France: A 14-year-old teenager shot two teaching staff members at his high school. The investigation has been taken over by the National Anti-Terrorism Prosecutor’s Office
18:14
Magdalena Andersson failed to secure approval for a left-wing majority, but she will face an investiture vote on Thursday
18:04
Former Justice Minister Tudorel Toader emphasized that Georgescu remains subject to the preventive detention order until a final decision.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
